申请人:Auro Peptides Ltd
公开号:US10344069B2
公开(公告)日:2019-07-09
The present invention relates to a process for the preparation of Liraglutide, which comprises: a) synthesis of suitable fragments (protected) by solid phase peptide synthesis; b) coupling of the suitable fragments on solid support; c) concurrently cleaving the protected peptide from the solid support and de-protecting the peptide; d) purification of Liraglutide (crude) on reverse phase HPLC; e) isolating pure Liraglutide.
本发明涉及一种制备利拉鲁肽的工艺,该工艺包括:a) 通过固相肽合成法合成合适的片段(受保护的);b) 将合适的片段偶联在固体支持物上;c) 同时将受保护的肽从固体支持物上裂解并去保护肽;d) 在反相高效液相色谱法上纯化利拉鲁肽(粗品);e) 分离出纯净的利拉鲁肽。